Dithra Cotton-Lewis
Psychiatric/Mental Health · Las Vegas, NVNPI 1487159182
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.5% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,220, 9.8 times the $328 reported in 2021. Among psychiatric/mental health clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 227 payments — averaging $32.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neuronetics, Inc.$1K
- Alkermes, Inc.$939
- Otsuka America Pharmaceutical, Inc.$863
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$772
- E.r. Squibb & Sons, L.L.C.$341
- plus $1K from 10 others
What the payments were for
- Travel & lodging$5888%
- Food & beverage$6,81391%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $1,764 |
| Neuronetics, Inc. | 6 | $1,455 |
| Alkermes, Inc. | 26 | $939 |
| Otsuka America Pharmaceutical, Inc. | 44 | $863 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $772 |
| E.r. Squibb & Sons, L.L.C. | 18 | $341 |
| Teva Pharmaceuticals USA, Inc. | 12 | $308 |
| Vanda Pharmaceuticals Inc. | 5 | $179 |
| Lundbeck LLC | 12 | $173 |
| Johnson & Johnson | 9 | $170 |
| Axsome Therapeutics, Inc. | 6 | $152 |
| Almatica Pharma LLC | 7 | $140 |
| Neurocrine Biosciences, Inc. | 5 | $115 |
| Forte Bio-pharma LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,409
- NEUROSTAR TMS THERAPY SYSTEM$1,317
- VRAYLAR$1,009
- ARISTADA$461
- CAPLYTA$370
- UZEDY$119
- ARISTADA INITIO$115
- REXULTI$111
How this compares
$7,448 in reported general payments places this provider in the 95th percentile of 362 psychiatric/mental health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 30 | $987 |
| Hydroxyzine Pamoate | 70 | $699 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $586 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $535 |
| Quetiapine Fumarate | 63 | $516 |
| Duloxetine Hcl | 18 | $453 |
| Oxycodone Hcl | 18 | $407 |
| Gabapentin | 52 | $396 |
| Buspirone Hcl | 49 | $349 |
| Hydroxyzine Hcl | 20 | $318 |
| Bupropion XlBupropion Hcl | 51 | $314 |
| Trazodone Hcl | 38 | $247 |
| Ibuprofen | 26 | $236 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $201 |
| Triamcinolone Acetonide | 23 | $183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $140 | $4417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 362 psychiatric/mental health providers in Nevada.
Other psychiatric/mental health in Las Vegas
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
- Joshua HamiltonLas Vegas$17K
- Sydney EganLas Vegas$14K
- Ma Victoria EscardaLas Vegas$12K
- Carminia SalvacionLas Vegas$12K
- Valentina AkohLas Vegas$12K
- Angela WilsonLas Vegas$11K
- Michael MathisenLas Vegas$10K
- Edina BorosLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.